HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mario Rizzetto Selected Research

Hepatitis D

10/2022Liver Transplantation in Hepatitis B/Hepatitis D (Delta) Virus Coinfected Recipients.
3/2022Clinical Application of Droplet Digital PCR for Hepatitis Delta Virus Quantification.
11/2021The hepatitis D virus in Italy. A vanishing infection, not yet a vanished disease.
1/2018Are immunoglobulins against the HBsAg still needed in liver transplantation for hepatitis D?
1/2018Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8+ T Cells.
9/2017Investigational drugs in development for Hepatitis D.
1/2016Chronic Hepatitis D; at a Standstill?
10/2015The prenylation inhibitor, lonafarnib: a new therapeutic strategy against hepatitis delta.
7/2015Hepatitis D Virus: Introduction and Epidemiology.
1/2014Chronic hepatitis D at a standstill: where do we go from here?
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mario Rizzetto Research Topics

Disease

38Infections
10/2022 - 04/2002
38Fibrosis (Cirrhosis)
11/2019 - 01/2004
24Chronic Hepatitis C
02/2022 - 10/2002
20Chronic Hepatitis B
02/2022 - 04/2002
15Hepatitis B
10/2022 - 07/2002
12Hepatocellular Carcinoma (Hepatoma)
10/2019 - 10/2004
11Hepatitis D
10/2022 - 01/2010
11Liver Diseases (Liver Disease)
02/2022 - 10/2004
10Insulin Resistance
01/2018 - 02/2002
10Liver Cirrhosis (Hepatic Cirrhosis)
01/2014 - 05/2005
9Chronic Hepatitis D
01/2018 - 09/2006
8Non-alcoholic Fatty Liver Disease
01/2016 - 04/2003
7Viremia
03/2022 - 10/2002
7Hepatitis
02/2022 - 08/2002
7Hepatitis C
03/2019 - 08/2002
7Anemia
11/2014 - 08/2002
7Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
09/2014 - 02/2005
6Ulcerative Colitis
08/2012 - 02/2005
6Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2009 - 02/2002
5Type 2 Diabetes Mellitus (MODY)
10/2019 - 10/2008
5Chronic Hepatitis (Chronic Active Hepatitis)
01/2019 - 10/2004
5Virus Diseases (Viral Diseases)
01/2018 - 12/2002
5Hemorrhage
09/2014 - 06/2004
5Portal Hypertension
09/2014 - 02/2002
4Ascites
08/2015 - 06/2004
3Superinfection
11/2019 - 01/2013
3End Stage Liver Disease
08/2015 - 06/2004
3Hemolytic Anemia
09/2014 - 04/2012
3Esophageal and Gastric Varices (Esophageal Varices)
09/2014 - 02/2007
3Neoplasms (Cancer)
09/2014 - 03/2013
3Crohn Disease (Crohn's Disease)
10/2008 - 02/2005
2Hypertension (High Blood Pressure)
10/2019 - 05/2002
2Leukopenia
08/2012 - 08/2002
2Colorectal Neoplasms (Colorectal Cancer)
03/2009 - 02/2004
2Hypertriglyceridemia
12/2006 - 07/2002
2Renal Insufficiency (Renal Failure)
06/2004 - 12/2002
2Iron Overload
01/2004 - 09/2002
1Reinfection
10/2022
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2021

Drug/Important Bio-Agent (IBA)

26Hepatitis B Surface Antigens (HBsAg)FDA Link
10/2022 - 03/2004
22Ribavirin (Virazole)FDA LinkGeneric
03/2019 - 08/2002
22InterferonsIBA
03/2019 - 08/2002
20Antiviral Agents (Antivirals)IBA
10/2022 - 02/2003
12Glucose (Dextrose)FDA LinkGeneric
10/2019 - 05/2002
12Lamivudine (Epivir)FDA Link
06/2012 - 04/2002
11DNA (Deoxyribonucleic Acid)IBA
04/2020 - 04/2005
11Hepatitis B e AntigensIBA
01/2019 - 04/2002
10RNA (Ribonucleic Acid)IBA
03/2022 - 10/2002
5Immunoglobulins (Immunoglobulin)IBA
10/2022 - 04/2005
5AntibodiesIBA
04/2020 - 05/2002
4Proteins (Proteins, Gene)FDA Link
02/2022 - 10/2008
4Insulin (Novolin)FDA Link
01/2016 - 02/2002
4Pharmaceutical PreparationsIBA
09/2014 - 12/2003
4Mesalamine (Mesalazine)FDA LinkGeneric
08/2012 - 03/2005
4Transaminases (Aminotransferases)IBA
12/2006 - 07/2002
3AntigensIBA
11/2021 - 11/2012
3hepatitis B hyperimmune globulinIBA
01/2021 - 04/2005
3Immunoglobulin G (IgG)IBA
04/2020 - 05/2002
3SofosbuvirIBA
03/2019 - 06/2016
3peginterferon alfa-2a (Pegasys)FDA Link
01/2019 - 06/2011
3lonafarnib (SCH 66336)IBA
01/2018 - 10/2015
3Interferon-alpha (Interferon Alfa)IBA
01/2018 - 08/2005
3alpha-Fetoproteins (alpha-Fetoprotein)IBA
12/2017 - 08/2004
3telaprevirIBA
09/2014 - 06/2011
3Azathioprine (Imuran)FDA LinkGeneric
09/2014 - 06/2009
3CytokinesIBA
01/2014 - 05/2002
3entecavirFDA Link
01/2013 - 10/2005
3CholesterolIBA
12/2006 - 05/2002
3adefovir dipivoxil (Hepsera)FDA Link
12/2006 - 02/2003
3Triglycerides (Triacylglycerol)IBA
06/2005 - 07/2002
3Angiotensin IIIBA
03/2004 - 02/2002
3IronIBA
01/2004 - 07/2002
2NucleotidesIBA
02/2022 - 02/2003
2Biological ProductsIBA
02/2022 - 01/2003
2Biomarkers (Surrogate Marker)IBA
01/2019 - 12/2017
2VaccinesIBA
01/2018 - 07/2002
2acarboxyprothrombin (PIVKA)IBA
12/2017 - 03/2016
2sofosbuvir drug combination ledipasvirIBA
05/2017 - 06/2016
2Cytidine Triphosphate (CTP)IBA
06/2016 - 10/2004
2N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
11/2014 - 09/2014
2Inosine TriphosphataseIBA
10/2013 - 04/2012
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2013 - 07/2006
2Cyclosporine (Ciclosporin)FDA LinkGeneric
08/2012 - 06/2009
2SteroidsIBA
06/2009 - 07/2008
2Capsules (Microcapsules)IBA
07/2007 - 04/2005
2EnzymesIBA
12/2006 - 05/2005
2Ferritins (Ferritin)IBA
12/2006 - 01/2004
2AdiponectinIBA
11/2005 - 06/2005
2AntioxidantsIBA
05/2005 - 04/2003
2PolyestersIBA
10/2004 - 11/2002
2Interferon alpha-2 (Roferon-A)FDA Link
10/2002 - 08/2002
1NucleosidesIBA
02/2022

Therapy/Procedure

48Therapeutics
02/2022 - 08/2002
15Liver Transplantation
10/2022 - 07/2002
5Transplantation
01/2021 - 03/2004
2Duration of Therapy
03/2019 - 03/2004
2Ligation
09/2014 - 07/2011
2Radiofrequency Ablation
07/2013 - 01/2008
2Stents
10/2004 - 11/2002
2Surgical Portasystemic Shunt (Portosystemic Shunt)
06/2004 - 12/2002